UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16

Under The Securities Exchange Act of 1934

 

For the month of August 2012

 

Commission File Number: 1-13064

 

NOVA Chemicals Corporation

 

1000 Seventh Avenue S.W., Calgary, Alberta, Canada, T2P 5L5

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x                                                                                                                                                                                                                   Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

A copy of the Registrant’s:

 

(a)                          Interim financial statements and interim Management’s Discussion & Analysis for the second quarter, three months ended June 30, 2012;

(b)                         Section 302 certification of principal executive officer; and

(c)                          Section 302 certification of principal financial officer;

 

are furnished herewith.

 

Controls and Procedures

 

(a)                                        Evaluation of disclosure controls and procedures.  Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of June 30, 2012, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

(b)                                         Changes in internal controls.  There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended June 30, 2012 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

NOVA Chemicals Corporation

 

 

 

 

 

/s/ Alan S. Pretter

 

  Alan S. Pretter

 

  Corporate Secretary

 

 

August 9, 2012

 

2


 

EXHIBITS

 

Attached hereto is:

 

99.1

 

Interim financial statements and interim Management’s Discussion & Analysis of NOVA Chemicals Corporation for the second quarter, three months ended June 30, 2012;

 

 

 

99.2

 

Section 302 certification of principal executive officer; and

 

 

 

99.3

 

Section 302 certification of principal financial officer.

 

3